Luca Rubino

1.8k total citations · 1 hit paper
21 papers, 1.3k citations indexed

About

Luca Rubino is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Rubino has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Rubino's work include Immune cells in cancer (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Luca Rubino is often cited by papers focused on Immune cells in cancer (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Luca Rubino collaborates with scholars based in Italy, Singapore and Germany. Luca Rubino's co-authors include Antonio Sica, Chiara Porta, Paola Larghi, Alessandra Mancino, Alberto Mantovani, Paola Allavena, Monica Rimoldi, Maria Grazia Totaro, Subhra K. Biswas and Graziella Solinas and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Luca Rubino

20 papers receiving 1.2k citations

Hit Papers

Macrophage polarization in tumour progression 2008 2026 2014 2020 2008 250 500 750

Peers

Luca Rubino
Sun-Hwa Kim South Korea
Kyle K. Payne United States
Jie Wei China
Dayson Moreira United States
Joel Crespo United States
Jens Volkmer United States
Stephanie K. Bunt United States
Sun-Hwa Kim South Korea
Luca Rubino
Citations per year, relative to Luca Rubino Luca Rubino (= 1×) peers Sun-Hwa Kim

Countries citing papers authored by Luca Rubino

Since Specialization
Citations

This map shows the geographic impact of Luca Rubino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Rubino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Rubino more than expected).

Fields of papers citing papers by Luca Rubino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Rubino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Rubino. The network helps show where Luca Rubino may publish in the future.

Co-authorship network of co-authors of Luca Rubino

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Rubino. A scholar is included among the top collaborators of Luca Rubino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Rubino. Luca Rubino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Brambilla, Luigi, et al.. (2022). Polyhydroxylated Nanosized Graphite as Multifunctional Building Block for Polyurethanes. Polymers. 14(6). 1159–1159. 2 indexed citations
3.
Asselta, Rosanna, Luca Di Tommaso, Matteo Perrino, et al.. (2021). Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature. Thoracic Cancer. 12(9). 1271–1278. 11 indexed citations
4.
Pastori, Daniele, Gregory Y.H. Lip, Daniela Poli, et al.. (2020). Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study. British Journal of Haematology. 190(4). 588–593. 13 indexed citations
5.
Pastori, Daniele, Evaristo Ettorre, Roberto Carnevale, et al.. (2019). Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort. Atherosclerosis. 289. 195–200. 20 indexed citations
6.
Personeni, Nicola, Marina Baretti, Silvia Bozzarelli, et al.. (2016). Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Gastric Cancer. 20(3). 428–437. 4 indexed citations
7.
Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2015). FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. Clinical Colorectal Cancer. 14(3). 162–169. 9 indexed citations
8.
Talotta, Carmen, Luca Rubino, Carmine Gaeta, et al.. (2015). Synthesis and supramolecular features of hybrid POM/onium solid-state assemblies. Supramolecular chemistry. 28(5-6). 403–417. 2 indexed citations
10.
Locatelli, Silvia L., Giuliano Giuseppe Stirparo, Silvia Tartari, et al.. (2013). The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts. Blood. 122(21). 3067–3067. 1 indexed citations
11.
Simonelli, Matteo, Paolo Andrea Zucali, Elena Lorenzi, et al.. (2012). Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors. European Journal of Cancer. 49(5). 989–998. 12 indexed citations
12.
Finocchiaro, Giovanna, Luca Toschi, Letizia Gianoncelli, et al.. (2012). TGFb expression as predictor of outcome in EGFR wild type (WT) metastatic non-small cell lung cancer (NSCLC) patients (PTS) treated with EGFR tyrosine kinase inhibitors (TKIs).. Journal of Clinical Oncology. 30(15_suppl). e18104–e18104. 1 indexed citations
13.
Gianoncelli, Letizia, Luca Toschi, Luca Rubino, et al.. (2012). Expression of folate pathway regulators and pemetrexed (pem) activity in patients (pts) with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 30(15_suppl). 7585–7585. 1 indexed citations
14.
Tomao, Paola, Agnese Martini, Silvia Capanna, et al.. (2011). Screening for tuberculosis among homeless shelter staff. American Journal of Infection Control. 40(5). 459–461. 5 indexed citations
15.
Doni, Andrea, Giovanna Mantovani, Chiara Porta, et al.. (2008). Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells. Journal of Biological Chemistry. 283(44). 29983–29992. 71 indexed citations
16.
Sica, Antonio, Paola Larghi, Alessandra Mancino, et al.. (2008). Macrophage polarization in tumour progression. Seminars in Cancer Biology. 18(5). 349–355. 964 indexed citations breakdown →
17.
Martini, Agnese, Paola Tomao, Nicoletta Vonesch, et al.. (2008). [QuantiFERON-TB Gold test in homeless shelter staff: preliminary results].. PubMed. 29(3 Suppl). 767–9. 3 indexed citations
18.
Porta, Chiara, et al.. (2007). Tumor Promotion by Tumor-Associated Macrophages. Advances in experimental medicine and biology. 604. 67–86. 77 indexed citations
19.
Sica, Antonio, Luca Rubino, Alessandra Mancino, et al.. (2007). Targeting tumour-associated macrophages. Expert Opinion on Therapeutic Targets. 11(9). 1219–1229. 50 indexed citations
20.
Mantovani, Alberto, Chiara Porta, Luca Rubino, Paola Allavena, & Antonio Sica. (2006). Tumor-associated macrophages (TAMs) as new target in anticancer therapy. Drug Discovery Today Therapeutic Strategies. 3(3). 361–366. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026